Close

DexCom (DXCM) says not in active discussions regarding a merger transaction at this time following Insulet (PODD) rumors

May 31, 2022 8:31 AM EDT

DexCom, Inc. (NASDAQ: DXCM) today issued the following statement in response to recent media and market speculation:

“Like many companies, Dexcom’s Board and management team regularly review opportunities to enhance stockholder value and create benefits for customers, including through mergers and acquisitions. It is generally our policy not to comment on rumors or speculation, however, in light of recent sustained media and market speculation as well as the upcoming American Diabetes Association conference, we wish to confirm that Dexcom is not in active discussions regarding a merger transaction at this time. We do not intend to comment further on this topic and we assume no obligation to make any further announcement or disclosure should circumstances change.”

Recent rumors had the company in talks to acquire Insulet (NASDAQ: PODD).



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Hot M&A, Mergers and Acquisitions

Related Entities

Definitive Agreement